Workflow
Crinetics Pharmaceuticals(CRNX)
icon
Search documents
Crinetics Pharmaceuticals(CRNX) - 2018 Q4 - Annual Report
2019-03-13 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | |--------------------------------------------------------------------------------------------------------------|-----------------------------------------------------| | For the transi ...
Crinetics Pharmaceuticals (CRNX) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow
2019-01-10 15:15
1&rporate Presentation !"#$"%&'()*+' Safe harbor statement This presentation contains forward-looking statements. All statements other than statements of historical facts contained in this presentation, including statements regarding our future results of operations and financial position, business strategy, prospective product approvals, research and development costs, timing and likelihood of success, plans and objectives of management for future operations, and future results of current and anticipated p ...